P
US12570599B2ActiveUtilityPatentIndex 59

Process for preparing acyl-capped 3-hydroxycarboxylic acids and their salts and esters

Assignee: KETOLIPIX THERAPEUTICS GMBHPriority: Jun 12, 2019Filed: Jun 12, 2019Granted: Mar 10, 2026
Est. expiryJun 12, 2039(~12.9 yrs left)· nominal 20-yr term from priority
Inventors:LOCHMANN DIRKREYER SEBASTIANSTEHR MICHAEL
C12P 7/62C12N 9/20C07C 67/02A61P 3/00C07C 69/716C07C 69/72
59
PatentIndex Score
0
Cited by
17
References
8
Claims

Abstract

The invention relates to a method for producing optionally functionalized acyl-capped (acyl-blocked) 3-hydroxybutyric acids and their salts and esters as well as to the products thus obtained and their use.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
         1 . A functionalized acyl-capped 3-hydroxybutyric ester,
 wherein the functionalized acyl-capped 3-hydroxybutyric ester corresponds to general formula (III″)
   CH 3 —CH(OR 3 )—CH 2 —C(O)OR 4   (III″)
 
   wherein, in the general formula (III″), the radical R 3  represents a radical CH 3 —C(O)—CH 2 —C(O)— and the radical R 4  represents a linear or branched, saturated or mono- or polyunsaturated aliphatic C 6 -C 30 -alkyl radical.   
     
     
         2 . The functionalized acyl-capped 3-hydroxybutyric ester according to  claim 1 ,
 wherein the functionalized acyl-capped 3-hydroxybutyric ester corresponds to general formula (III″)
   CH 3 —CH(OR 3 )—CH 2 —C(O)OR 4   (III″)
 
   wherein, in the general formula (III″), the radical R 3  represents a radical CH 3 —C(O)—CH 2 —C(O)— and the radical R 4  represents a linear or branched, saturated or mono- or polyunsaturated aliphatic C 10 -C 30 -alkyl radical.   
     
     
         3 . The functionalized acyl-capped 3-hydroxybutyric ester according to  claim 1 ,
 wherein the functionalized acyl-capped 3-hydroxybutyric ester corresponds to general formula (III″)
   CH 3 —CH(OR 3 )—CH 2 —C(O)OR 4   (III″)
 
   wherein, in the general formula (III″), the radical R 3  represents a radical CH 3 —C(O)—CH 2 —C(O)— and the radical R 4  represents a linear or branched, saturated or mono- or polyunsaturated aliphatic C 10 -C 24 -alkyl radical.   
     
     
         4 . A mixture comprising at least two different functionalized acyl-capped 3-hydroxybutyric esters, as defined in  claim 1 . 
     
     
         5 . A pharmaceutical composition comprising at least one functionalized acyl-capped 3-hydroxybutyric ester, as defined in  claim 1 . 
     
     
         6 . The pharmaceutical composition according to  claim 5 ,
 wherein the pharmaceutical composition is a drug or medicament.   
     
     
         7 . A food or a food product comprising at least one functionalized acyl-capped 3-hydroxybutyric ester, as defined in  claim 1 . 
     
     
         8 . A functionalized acyl-capped 3-hydroxybutyric ester,
 wherein the functionalized acyl-capped 3-hydroxybutyric ester corresponds to general formula (III″)
   CH 3 —CH(OR 3 )—CH 2 —C(O)OR 4   (III″)
 
   wherein, in the general formula (III″), the radical R 3  represents a radical CH 3 —C(O)—CH 2 —C(O)— and the radical R 4  represents a linear or branched, saturated or mono- or polyunsaturated aliphatic C 10 -C 30 -alkyl radical.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.